• Dr. Jodie Dionne-Odom is an Associate Professor of Medicine in the Division of Infectious Diseases, Chief of Women's Health at the 1917 HIV Clinic, and the Associate Director of Global Health in the UAB Center for Women's Reproductive Health. As a physician-scientist, she leads clinical trials to identify new ways to treat and prevent infections in women and pregnancy.

    Dr. Dionne works to improve women's health in the US and in Africa. Her current global health research focuses on preventing malaria, sexually transmitted infections, and hepatitis B among pregnant women in Cameroon and Zambia. She also leads multicenter clinical trials in the US focused on the treatment and prevention of syphilis and gonorrhea. She is a member of the CDC/HRSA advisory committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC), the COVID-19 Taskforce for the American Society of Reproductive Medicine (ASRM), and the Alabama STD Medical Advisory Council. Dr. Dionne is also a research mentor for students and trainees working to improve infection outcomes in the US and in Africa.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 Trends in Bacterial Vaginosis Prevalence in a Cohort of U.S. Women with and at Risk for HIVJournal of Women's Health.  31:726-732. 2022
    2022 Associations between HIV, antiretroviral therapy and preterm birth in the US Women’s Interagency HIV Study, 1995–2018: a prospective cohortHIV Medicine.  23:406-416. 2022
    2022 Treatment and prevention of viral hepatitis in pregnancyAmerican Journal of Obstetrics and Gynecology.  226:335-346. 2022
    2022 Association between Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma genitalium, and Trichomonas vaginalis and Secondary Infertility in Cameroon: A case-control studyPLoS ONE.  17. 2022
    2022 Factors associated with syphilis seroprevalence in women with and at-risk for HIV infection in the Women's Interagency HIV Study (1994-2015)Sexually Transmitted Infections.  98:4-10. 2022
    2022 The Association Between HIV Status, Estradiol, and Sex Hormone Binding Globulin Among Premenopausal Women in the Women's Interagency HIV StudyJournal of Women's Health.  31:183-193. 2022
    2021 Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) VariantObstetrics and Gynecology.  138:842-844. 2021
    2021 Contraception Requirements in Clinical Trials: Considerations from Studies on Sexually Transmitted Infections 2021
    2021 Syphilis testing and diagnosis among people with HIV engaged in care at four United States clinical sites, 2014-2018.Clinical Infectious Diseases2021
    2021 Single Dose of Oral Azithromycin With or Without Amoxicillin to Prevent Peripartum Infection in Laboring, High-Risk Women in Cameroon: A Randomized Controlled TrialObstetrics and Gynecology.  138:703-713. 2021
    2021 Screening for Chlamydia and Gonorrhea 2021
    2021 Limited Utility of Reverse Algorithm Syphilis Testing in HIV Clinic among Men Who Have Sex with MenSexually Transmitted Diseases.  48:675-679. 2021
    2021 Pragmatic Experience with Risk-based versus Universal Hepatitis C Screening in Pregnancy: Detection of Infection and Postpartum Linkage to Care 2021
    2021 Prevalence of and Factors Associated with Genital and Extragenital Chlamydia and Gonorrhea among Transgender Women in HIV Care in the United States, 2005 to 2016Sexually Transmitted Diseases.  48:410-416. 2021
    2021 Chlamydia Prevalence by Age and Correlates of Infection among Pregnant WomenSexually Transmitted Diseases.  48:37-41. 2021
    2021 The impact of epidemiology on fertility and prenatal care during the COVID-19 pandemicAmerican Journal of Epidemiology.  190:701-706. 2021
    2020 High rates of persistent and recurrent chlamydia in pregnant women after treatment with azithromycin 2020
    2020 Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living with Human Immunodeficiency Virus in the United States (2005-2016)Clinical Infectious Diseases.  71:2405-2413. 2020
    2020 Cervicitis: Balancing the Goals of Empiric Therapy and Antimicrobial Stewardship to Improve Women's HealthSexually Transmitted Diseases.  47:387-388. 2020
    2020 Heart Failure with Preserved Ejection Fraction in a Postpartum Patient with Superimposed Preeclampsia and COVID-19American Journal of Perinatology Reports.  10:E165-E168. 2020
    2020 Coverage and effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) on adverse pregnancy outcomes in the Mount Cameroon area, South West CameroonMalaria Journal.  19. 2020
    2020 Performance of 4 Molecular Assays for Detection of Chlamydia and Gonorrhea in a Sample of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men.Sexually Transmitted Diseases.  47:158-161. 2020
    2019 A comparative analysis of documented contraceptive use among women aged 18–30 living with and without HIV in AlabamaContraception.  100:275-278. 2019
    2019 Miscarriage among women in the United States Women's Interagency HIV Study, 1994–2017American Journal of Obstetrics and Gynecology.  221:347.e1-347.e13. 2019
    2019 Prevalence of group B streptococcus anogenital colonization and feasibility of an intrapartum screening and antibiotic prophylaxis protocol in Cameroon, Africa 2019
    2019 Erectile Dysfunction Medication Prescription: STI and Risk Behavior in Men with HIV 2019
    2019 HIV Status and Contraceptive Utilization among Women in CameroonJournal of the International Association of Providers of AIDS Care.  18. 2019
    2019 HIV status and other risk factors for prevalent and incident sexually transmitted infection during pregnancy (2000-2014) 2019
    2018 Sexually Transmitted Infection Prevalence in Women with HIV: Is There a Role for Targeted Screening?Sexually Transmitted Diseases.  45:762-769. 2018
    2018 Large Outbreak of Hepatitis C Virus Associated with Drug Diversion by a Healthcare TechnicianClinical Infectious Diseases.  67:845-853. 2018
    2018 Elimination of Vertical Transmission of Hepatitis B in Africa: A Review of Available Tools and New Opportunities 2018
    2018 A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination 2018
    2018 High prevalence of multidrug-resistant mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in AlabamaClinical Infectious Diseases.  66:796-798. 2018
    2018 Hepatitis B virus contact disclosure and testing in Lusaka, Zambia: A mixed-methods studyBMJ Open.  8. 2018
    2018 Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose 2018
    2017 Predictors of the use of interventions to prevent malaria in pregnancy in CameroonMalaria Journal.  16. 2017
    2016 #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmissionAmerican Journal of Obstetrics and Gynecology.  214:6-14. 2016
    2016 Factors associated with PMTCT cascade completion in four african countriesAIDS Research and Treatment.  2016. 2016
    2016 Hepatitis B, HIV, and Syphilis Seroprevalence in Pregnant Women and Blood Donors in Cameroon 2016
    2016 Retention in Care among HIV-Infected Pregnant Women in Haiti with PMTCT Option BAIDS Research and Treatment.  2016. 2016
    2015 Normal T-cell activation in elite controllers with preserved CD4 + T-cell countsAIDS.  29:2245-2254. 2015
    2015 Law and the public’s health: Taken to court: Defending public health authority to access medical records during an outbreak investigationPublic Health Reports.  130:278-283. 2015
    2015 Taken to court: defending public health authority to access medical records during an outbreak investigation.Public Health Reports.  130:278-283. 2015
    2015 Preventing vertical transmission of hepatitis B: Guidance on management of pregnant patients with acute and chronic infectionContemporary OB/GYN.  60:44-50. 2015
    2014 Adapting and implementing a community program to improve retention in care among patients with hiv in southern haiti: "Group of 6"AIDS Research and Treatment.  2014. 2014
    2014 Performance of the OraQuick HCV rapid antibody test for screening exposed patients in a hepatitis c outbreak investigationJournal of Clinical Microbiology.  52:2650-2652. 2014
    2013 Fungal infections associated with contaminated methylprednisolone injections.New England Journal of Medicine.  369:1598-1609. 2013
    2013 Reply to Yang et alClinical Infectious Diseases.  57:1212-1213. 2013
    2013 Syphilis treatment response among HIV-discordant couples in Zambia and RwandaClinical Infectious Diseases.  56:1829-1837. 2013
    2013 Decrease in varicella incidence after implementation of the 2-dose recommendation for varicella vaccine in New Hampshire 2013
    2012 Exposure to nitrogen dioxide in an indoor ice arena - New Hampshire, 2011MMWR : Morbidity & Mortality Weekly Report.  61:139-142. 2012
    2011 Antimicrobial resistant gonorrhea in Atlanta: 1988-2006Sexually Transmitted Diseases.  38:780-782. 2011
    2010 Gastrointestinal anthrax after an animal-hide drumming event - New Hampshire and Massachusetts, 2009.MMWR : Morbidity & Mortality Weekly Report.  59:872-877. 2010
    2009 Acute hepatitis C and HIV coinfectionLancet Infectious Diseases.  9:775-783. 2009
    2007 Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetesJournal of Clinical Microbiology.  45:1648-1651. 2007


    Year Title Altmetric
    2017 Pituitary abscess: An uncommon condition requiring multidisciplinary care.  423-431. 2017
    2012 Tick-borne Illness 2012
    2009 Access to culturally competent care for patients living with HIV/AIDS.  69-82. 2009

    Research Overview

  • Dr. Dionne's research focus is to optimize the prevention and treatment of infections in women and pregnancy. Current studies test novel regimens to prevent malaria and STI in pregnant women with HIV (PREMISE Trial) and perinatal hepatitis B transmission (REVERT-B Trial) with support from NIH/NICHD and strong collaboration between UAB and scientists at the University of Buea in Cameroon. Clinical trials are conducted by a robust Cameroon Health Initiative Team (CHI UAB) with dedicated study staff who enroll participants at four busy research sites within a national hospital network system.

    Dr. Dionne also leads UAB research efforts as part of the NIAID-supported STI Clinical Trials Group with studies of promising new prevention options for gonorrhea (meningococcal group B vaccine), syphilis treatment options, and a new oral medication to treat gonorrhea (zoliflodacin). She is a Principal Investigator of the NIH MACS/WIHS Combined Cohort Study for women and men living with HIV. Dr. Dionne also works at UAB to help prevent vertical transmission of HIV and study the impact of COVID-19 in pregnancy.
  • Teaching Overview

  • Dr. Dionne is a highly-rated teacher, mentor and public speaker about infectious diseases. She teaches medical students, housestaff, and graduate students about infection in pregnancy and women's health.
  • Education And Training

  • New York University Medicine, Chief Resident
  • New York University School of Medicine Medicine, Internship
  • New York University Medicine, Residency
  • Emory University Medicine, Postdoctoral Fellowship
  • National Institutes of Health, Postdoctoral Fellowship
  • Doctor of Medicine, Dartmouth College 2002
  • Bachelor of Arts in Biology, University of Rochester 1998
  • Full Name

  • Jodie Dionne-Odom